AYUSH medicine as add-on therapy for mild category COVID-19; an open label randomised, controlled clinical trial.

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Medicine

Infectious Disease

DOI

10.1101/2020.12.06.20245019

License

CC-BY-NC-ND

Other Formats

PDF